Kazia Therapeutics (ASX:KZA) has announced the resignation of Iain Ross from his position as chairman of the company.
Subsequent to Ross’s departure, the biotech firm has elected John Friend as interim chairman.
Kazia Therapeutics is a biotech company focused on the discovery and development of innovative drugs for the treatment of cancer.
Global online trading services company, Plus500:
Plus500 trading platform allows you to trade shares from all popular markets such as USA, UK, Germany and more, with leverage and low spreads. Using our advanced trading tools, you can also control your profits and losses.
Plus500AU Pty Ltd, AFSL #417727 issued by Australian Securities and Investments Commission. Based in Sydney.
Receive whispers every day in your inbox.
